ANDHealth is delighted to be covered in international trade journal Medical Device Daily in their article Australia launches national digital health effort to commercialise disruptive technology, Quoting MD Bronwyn Le Grice “The most important thing in delivering a digital health technology that impacts the clinical outcome for a patient is that point in time where the technology needs to have an evidence basis and clinical validation in order to make it investable and viable as a medical product.” The article is appended below.

Medical Technologies and Pharmaceuticals Industry Growth Centre – MTPConnect – today announced it will provide $7.4 million of funding over two years for 14 national projects in the medtech, biotech and pharmaceutical (MTP) sector. One is ANDHealth, a consortium led by the Murdoch Children’s Research Institute. ANDHealth represents the first program of its kind focused on ‘moving the needle’ for digital health companies in Australia needing to consolidate either clinical and/ or commercial validation for their technologies/ businesses in order to successfully raise capital or enter into a significant commercial partnership.

Page 2 of 2 12